Aurora Cannabis Inc.

ACB

CA05156X8504

Pharmaceuticals

Delayed Toronto S.E. Other stock markets 10:47:45 2024-04-26 am EDT			5-day change	1st Jan Change
9.97 ^CAD	+8.84%		+12.29%	+53.23%

Apr. 02	Cannabis Stocks Rise Pre-Bell After Florida Supreme Court Allows Ballot Initiative to Legalize Marijuana	MT
Apr. 02	Pot producers climb as recreational cannabis to go on Florida ballot	RE

An Unknown buyer acquired Aurora Polaris facility from Aurora Cannabis Inc. for CAD 15 million.

January 03, 2023

An Unknown buyer acquired Aurora Polaris facility from Aurora Cannabis Inc. for CAD 15 million on January 4, 2023.

An Unknown buyer completed the acquisition of Aurora Polaris facility from Aurora Cannabis Inc. on January 4, 2023.

Latest news about Aurora Cannabis Inc.

Cannabis Stocks Rise Pre-Bell After Florida Supreme Court Allows Ballot Initiative to Legalize Marijuana	Apr. 02	MT
Pot producers climb as recreational cannabis to go on Florida ballot	Apr. 02	RE
Cannabis Stocks: Wedbush Notes Florida Supreme Court Approved Proposed Amendment For Adult Use Cannabis to be Placed on the 2024 General Election Ballot	Apr. 02	MT
High Tide, Aurora Cannabis Mixed In US Premarket Trade As Both Note Start of German Cannabis Legalization	Apr. 01	MT
Aurora Cannabis Brief: Notes Germany's "Landmark" Legalization Achievement; Says Expected De-scheduling of Cannabis to Fuel Expansion of Medical Cannabis Market in Germany	Apr. 01	MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Markets Take Breather After Last Week's Rally	Mar. 25	MT
US Equity Markets Close Mixed Friday as Dow Drops After Approaching 40,000	Mar. 22	MT
Sector Update: Consumer Stocks Slipping Late Afternoon	Mar. 22	MT
Sector Update: Consumer	Mar. 22	MT
Top Midday Gainers	Mar. 22	MT
Aurora, Canopy Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law	Mar. 22	MT
Aurora Cannabis, Canopy Growth Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law	Mar. 22	MT
Aurora Cannabis, Canopy Growth Among Cannabis Stocks Rising After Germany Passes Partial Legalization Law	Mar. 22	MT
Cannabis Review Panel Recommends Changes to Excise Tax, Health Canada Regulations	Mar. 22	MT
Aurora Cannabis Shares Rise After Receipt of Australian Regulator's Certification	Mar. 20	MT
Toronto Stocks Higher; Boyd Group Says New Locations to Weigh on Earnings	Mar. 20	DJ
Aurora Cannabis Secures Australia's TGA GMP Certification	Mar. 20	MT
Aurora Cannabis Brief: Says Achieved Australia's TGA GMP Certification	Mar. 20	MT
Sector Update: Consumer Stocks Higher in Late Afternoon Trading	Mar. 18	MT
Wedbush on "The Clock is Ticking on Cannabis"	Mar. 18	MT
Cannabis Stocks Rise Following White House Roundtable on Marijuana Reform	Mar. 18	MT
Cannabis Stocks Rise Following White House Roundtable on Marijuana Reform	Mar. 18	MT
Aurora Cannabis Introduces Medical Cannabis Pastilles for Patient Relief in Australia	Mar. 04	MT
Aurora Cannabis Reports Operations Are Now Debt Free	Feb. 29	MT
Aurora Cannabis Brief: Says Completed Final Repayment of Convertible Senior Notes Representing Near $465 Million in Total Repayments Since 2021	Feb. 29	MT

Chart Aurora Cannabis Inc.

Duration

Period

More charts

Company Profile

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Companyâs segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

Sector

Pharmaceuticals

Calendar

2024-05-08 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Aurora Cannabis Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

9.16 CAD

Average target price

9.681 CAD

Spread / Average Target

+5.69%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
AURORA CANNABIS INC.	+53.23%	365M
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.69%	4.49B
TASLY PHARMACEUTICAL GROUP CO., LTD	-12.46%	3.06B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.12%	3.04B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+0.47%	2.61B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+36.06%	1.81B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.84%	1.66B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.60%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.03%	1.55B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+36.40%	1.41B

Alternative Medicine

Aurora Cannabis Inc.

Equities

ACB

CA05156X8504

Pharmaceuticals

An Unknown buyer acquired Aurora Polaris facility from Aurora Cannabis Inc. for CAD 15 million.

EPS Revisions